In the largest study of its kind, scientists today report how combining health data with whole genome sequence (WGS) data in patients with cancer can help doctors provide more tailored care for their patients.
This research uncovered significant findings across different cancer types, such as:
- Over 90% of brain tumours and over 50% of colon and lung cancers showed genetic changes that could affect how patients are treated, guiding decisions about surgery or specific treatments they might need.
- In more than 10% of sarcomas, larger DNA changes, known as structural variants, were identified that can impact clinical care and treatment.
- In over 10% of ovarian cancers, the study pinpointed inherited risks offering crucial insights for clinical care.
The findings show the value of combining genomic and clinical data at scale to help healthcare professionals make the best treatment decisions with their patients.
Lynch Syndrome Ireland 